Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Sabra Healthcare REIT Inc’s stock clocked out at $19.27, down -0.72% from its previous closing price of $19.41. In other words, the price has decreased by -$0.72 from its previous closing price. On the day, 2.06 million shares were traded. SBRA stock price reached its highest trading level at $19.48 during the session, while it also had its lowest trading level at $19.041.
Ratios:
To gain a deeper understanding of SBRA’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 23.15 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.86. For the most recent quarter (mrq), Quick Ratio is recorded 1.67 and its Current Ratio is at 1.67. In the meantime, Its Debt-to-Equity ratio is 0.93 whereas as Long-Term Debt/Eq ratio is at 0.93.
Upgrades & Downgrades
In the most recent recommendation for this company, UBS on November 18, 2025, initiated with a Neutral rating and assigned the stock a target price of $20.
On October 01, 2025, Cantor Fitzgerald started tracking the stock assigning a Neutral rating and target price of $20.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 20 ’25 when FOSTER MICHAEL J sold 11,000 shares for $18.22 per share. The transaction valued at 200,376 led to the insider holds 64,725 shares of the business.
Michael J. Foster bought 11,000 shares of SBRA for $192,500 on May 15 ’25. On Feb 24 ’25, another insider, Cusack Catherine, who serves as the Director of the company, bought 1,500 shares for $15.92 each. As a result, the insider paid 23,880 and bolstered with 60,583 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SBRA now has a Market Capitalization of 4804968448 and an Enterprise Value of 7203684352. As of this moment, Sabra’s Price-to-Earnings (P/E) ratio for their current fiscal year is 26.50, and their Forward P/E ratio for the next fiscal year is 25.62. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.85. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.42 while its Price-to-Book (P/B) ratio in mrq is 1.70. Its current Enterprise Value per Revenue stands at 9.643 whereas that against EBITDA is 15.81.
Stock Price History:
The Beta on a monthly basis for SBRA is 0.65, which has changed by 0.12980211 over the last 52 weeks, in comparison to a change of 0.17287207 over the same period for the S&P500. Over the past 52 weeks, SBRA has reached a high of $19.97, while it has fallen to a 52-week low of $15.60. The 50-Day Moving Average of the stock is 1.65%, while the 200-Day Moving Average is calculated to be 4.91%.
Shares Statistics:
It appears that SBRA traded 2.83M shares on average per day over the past three months and 2379070 shares per day over the past ten days. A total of 249.35M shares are outstanding, with a floating share count of 244.78M. Insiders hold about 1.83% of the company’s shares, while institutions hold 96.10% stake in the company. Shares short for SBRA as of 1767139200 were 22710045 with a Short Ratio of 8.02, compared to 1764288000 on 23647917. Therefore, it implies a Short% of Shares Outstanding of 22710045 and a Short% of Float of 12.620000000000001.
Dividends & Splits
With its trailing 12-month dividend rate of 1.2, SBRA has a forward annual dividend rate of 1.20. Against a Trailing Annual Dividend Yield of 0.061823804. The stock’s 5-year Average Dividend Yield is 8.02. The current Payout Ratio is 223.55% for SBRA, which recently paid a dividend on 2025-11-17 with an ex-dividend date of 2025-11-17. Stock splits for the company last occurred on 2010-11-16 when the company split stock in a 1:3 ratio.
Earnings Estimates
. The current rating of Sabra Healthcare REIT Inc (SBRA) reflects the combined expertise of 2.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is $0.17, with high estimates of $0.17 and low estimates of $0.17.
Analysts are recommending an EPS of between $0.71 and $0.69 for the fiscal current year, implying an average EPS of $0.7. EPS for the following year is $0.75, with 2 analysts recommending between $0.77 and $0.73.
Revenue Estimates
In. The current quarter, 4 analysts expect revenue to total $204.26M. It ranges from a high estimate of $215.57M to a low estimate of $189.5M. As of. The current estimate, Sabra Healthcare REIT Inc’s year-ago sales were $182.35MFor the next quarter, 4 analysts are estimating revenue of $198.16M. There is a high estimate of $210.9M for the next quarter, whereas the lowest estimate is $182.22M.
A total of 5 analysts have provided revenue estimates for SBRA’s current fiscal year. The highest revenue estimate was $778.3M, while the lowest revenue estimate was $719.1M, resulting in an average revenue estimate of $751.37M. In the same quarter a year ago, actual revenue was $703.24MBased on 6 analysts’ estimates, the company’s revenue will be $833.87M in the next fiscal year. The high estimate is $975.79M and the low estimate is $739.68M.
